The validity period for the approval for 30 active substances has been extended by one year due to the delay in the re-evaluation following the application for renewal of the approval. If the review for any of the active ingredients leads to rejection of the renewal application in the meantime, the approval will expire with a corresponding order ahead of schedule.
We list the chemical active ingredients only.

 

 

The following active substances were extended by one year:

 

Active Ingredients

Limited until

Reference

Abamectin

04/30/2023

COMMISSION IMPLEMENTING REGULATION (EU) 2022/378 of 4 March 20221)

Clodinafop

Cyprodinil

Dichlorprop-P

Fenpyroximate

Fosetyl

Malathion

Mepanipyrim

Metconazole

Metrafenone

Pirimicarb

Pyrimethanil

Rimsulfuron

Spinosad

Triclopyr

Trinexapac

Triticonazole

Ziram

 

The lifetime extensions have no influence on the current maximum residue limits.

 

Link: https://eur-lex.europa.eu/

 

 

 

Author: Frank Mörsberger

Contact
 
 
Career